France
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
34.57%
|
Dec. 31, 2023 | USD 126.17 | 0.49% |
|
France |
|
2 |
32.44%
|
Dec. 31, 2023 | USD 38.11 | 0.79% |
|
France |
|
3 |
31.68%
|
Dec. 31, 2023 | USD 3.46 | -1.94% |
|
France |
|
4 |
27.23%
|
Dec. 31, 2023 | USD 221.40 | -1.05% |
|
France |
|
5 |
26.06%
|
Dec. 31, 2023 | USD 107.71 | -0.06% |
|
France |
|
6 |
22.25%
|
June 30, 2024 | USD 3.57 | 0.41% |
|
France |
|
7 |
20.65%
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
|
8 |
19.65%
|
Dec. 31, 2023 | USD 24.56 | 7.32% |
|
France |
|
9 |
19.07%
|
Dec. 31, 2023 | USD 118.59 | -2.39% |
|
France |
|
10 |
18.79%
|
Dec. 31, 2023 | USD 26.53 | 0.03% |
|
France |
|
11 |
18.17%
|
Dec. 31, 2023 | USD 2.64 | 6.09% |
|
France |
|
12 |
15.46%
|
Dec. 31, 2023 | USD 12.51 | 0.24% |
|
France |
|
13 |
14.94%
|
Dec. 31, 2023 | USD 26.48 | 0.03% |
|
France |
|
14 |
11.68%
|
June 30, 2024 | USD 10.22 | -7.76% |
|
France |
|
15 |
6.97%
|
Dec. 31, 2023 | USD 3.26 | -0.17% |
|
France |
|
16 |
-14.60%
|
Dec. 31, 2023 | USD 2.09 | 3.97% |
|
France |
|
17 |
-37.55%
|
Dec. 31, 2023 | USD 3.46 | 7.58% |
|
France |
|
18 |
-50.59%
|
Dec. 31, 2023 | USD 2.39 | -7.42% |
|
France |
|
19 |
-70.91%
|
Dec. 31, 2023 | USD 1.26 | -0.99% |
|
France |
|
20 |
-77.84%
|
Dec. 31, 2023 | USD 3.95 | 0.89% |
|
France |
|
21 |
-88.12%
|
Dec. 31, 2023 | USD 3.27 | -7.78% |
|
France |
|
22 |
-100.09%
|
Dec. 31, 2023 | USD 3.58 | 3.12% |
|
France |
|
23 |
-135.45%
|
Dec. 31, 2023 | USD 1.42 | 2.06% |
|
France |
|
24 |
-155.83%
|
March 31, 2024 | USD 17.01 | 1.06% |
|
France |
|
25 |
-157.55%
|
Dec. 31, 2023 | USD 0.63 | -3.60% |
|
France |
|
26 |
-198.16%
|
Dec. 31, 2023 | USD 2.07 | 0.33% |
|
France |
|
27 |
-523.35%
|
Dec. 31, 2023 | USD 1.59 | 0.49% |
|
France |
|
28 |
-583.86%
|
Dec. 31, 2023 | USD 2.40 | -1.45% |
|
France |
|
29 |
-785.86%
|
Dec. 31, 2023 | USD 6.79 | 2.49% |
|
France |
|
30 |
-886.00%
|
Dec. 31, 2023 | USD 7.79 | 1.73% |
|
France |
|
31 |
-900.14%
|
Dec. 31, 2023 | USD 5.82 | 3.14% |
|
France |
|
32 |
-956.80%
|
Dec. 31, 2023 | USD 1.64 | -0.17% |
|
France |
|
33 |
-2,882.64%
|
Dec. 31, 2023 | USD 6.04 | 2.29% |
|
France |
|
34 |
-5,031.72%
|
Dec. 31, 2023 | USD 1.97 | -2.73% |
|
France |
|
35 |
-12,269.67%
|
Dec. 31, 2023 | USD 1.63 | 1.12% |
|
France |
The Healthcare company in France with the highest EBITDA Margin is Ipsen S.A. (Paris Stock Exchange: IPN.PA) at 34.57%.
The Healthcare company in France with the lowest EBITDA Margin is Cellectis S.A. (Paris Stock Exchange: ALCLS.PA) at -12,269.67%.
The top 10 Healthcare companies in France by EBITDA Margin are Ipsen S.A., Equasens SA, genOway SA, Sartorius Stedim Biotech S.A., Sanofi, Amplitude Surgical SA, Eurofins-Cerep SA, LNA Santé SA, bioMérieux S.A. and Eurobio Scientific SA.
The bottom 10 Healthcare companies in France by EBITDA Margin are Cellectis S.A., Crossject SA, ABIVAX SA, AB Science S.A., Adocia SA, MaaT Pharma SA, OSE Immunotherapeutics SA, Inventiva S.A., Ikonisys S.A. and Advicenne S.A..